American International Group, Inc. Akero Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.76 - $31.18 $85,461 - $150,038	4,812 Added 18.86%	30,326 $766,000
Q4 2023 Feb 13, 2024	SELL	$11.38 - $50.33 $1,172 - $5,183	-103 Reduced 0.4%	25,514 $595,000
Q3 2023 Nov 13, 2023	BUY	$41.19 - $52.25 $164,471 - $208,634	3,993 Added 18.47%	25,617 $1.3 Million
Q2 2023 Aug 04, 2023	BUY	$36.89 - $56.88 $177,035 - $272,967	4,799 Added 28.52%	21,624 $1.01 Million
Q1 2023 May 12, 2023	BUY	$37.27 - $50.24 $12,448 - $16,780	334 Added 2.03%	16,825 $643,000
Q4 2022 Feb 10, 2023	BUY	$33.44 - $54.8 $106,773 - $174,976	3,193 Added 24.01%	16,491 $903,000
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $1,908 - $6,401	188 Added 1.43%	13,298 $453,000
Q2 2022 Aug 12, 2022	BUY	$8.0 - $15.01 $2,760 - $5,178	345 Added 2.7%	13,110 $124,000
Q1 2022 May 13, 2022	SELL	$12.97 - $22.26 $11,647 - $19,989	-898 Reduced 6.57%	12,765 $181,000
Q4 2021 Feb 11, 2022	SELL	$19.87 - $26.24 $8,126 - $10,732	-409 Reduced 2.91%	13,663 $289,000
Q3 2021 Nov 12, 2021	SELL	$18.65 - $25.46 $6,229 - $8,503	-334 Reduced 2.32%	14,072 $315,000
Q2 2021 Aug 13, 2021	BUY	$24.81 - $32.35 $161,637 - $210,760	6,515 Added 82.56%	14,406 $357,000
Q1 2021 May 07, 2021	BUY	$24.04 - $34.19 $504 - $717	21 Added 0.27%	7,891 $229,000
Q4 2020 Feb 12, 2021	SELL	$25.12 - $29.89 $5,677 - $6,755	-226 Reduced 2.79%	7,870 $203,000
Q3 2020 Nov 04, 2020	BUY	$30.79 - $39.92 $38,641 - $50,099	1,255 Added 18.35%	8,096 $249,000
Q2 2020 Aug 12, 2020	BUY	$19.25 - $26.76 $36,286 - $50,442	1,885 Added 38.03%	6,841 $170,000
Q1 2020 May 04, 2020	BUY	$12.8 - $27.05 $24,243 - $51,232	1,894 Added 61.85%	4,956 $105,000
Q4 2019 Feb 05, 2020	BUY	$17.37 - $27.27 $764 - $1,199	44 Added 1.46%	3,062 $68,000
Q3 2019 Nov 08, 2019	BUY	$16.89 - $29.88 $50,974 - $90,177	3,018 New	3,018 $69,000

Others Institutions Holding AKRO

# of Institutions

168

Shares Held

72.7M

Call Options Held

178K

Put Options Held

164K

Janus Henderson Group PLC London, X0

6.88M
Shares

$194 Million
0.09% of portfolio
Black Rock Inc. New York, NY

5.59M
Shares

$158 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.43M
Shares

$153 Million
2.13% of portfolio
General Atlantic LLC New York, NY

5.23M
Shares

$148 Million
3.88% of portfolio
Wellington Management Group LLP Boston, MA

5.11M
Shares

$144 Million
0.02% of portfolio

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.31B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account